In vitro neuraminidase inhibitory concentration (IC
Antiviral Agents
/ therapeutic use
Enzyme Inhibitors
/ therapeutic use
Humans
Influenza A Virus, H1N1 Subtype
/ drug effects
Influenza A Virus, H3N2 Subtype
/ drug effects
Influenza, Human
/ drug therapy
Inhibitory Concentration 50
Japan
Neuraminidase
/ antagonists & inhibitors
Oseltamivir
/ therapeutic use
Seasons
50% inhibitory concentration
Influenza virus
Neuraminidase inhibitor
Resistance
Surveillance
Journal
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
ISSN: 1437-7780
Titre abrégé: J Infect Chemother
Pays: Netherlands
ID NLM: 9608375
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
received:
15
01
2019
revised:
11
03
2019
accepted:
10
04
2019
pubmed:
19
5
2019
medline:
18
12
2019
entrez:
19
5
2019
Statut:
ppublish
Résumé
To assess the extent of susceptibility to the four most commonly used neuraminidase inhibitors (NAIs) of the viruses epidemic in the 2017-18 Japanese influenza season, we measured the 50% inhibitory concentration (IC
Identifiants
pubmed: 31101530
pii: S1341-321X(19)30099-6
doi: 10.1016/j.jiac.2019.04.007
pii:
doi:
Substances chimiques
Antiviral Agents
0
Enzyme Inhibitors
0
Oseltamivir
20O93L6F9H
Neuraminidase
EC 3.2.1.18
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
649-652Informations de copyright
Copyright © 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.